. 2006 Oct;82(972):672–678. doi: 10.1136/pgmj.2006.045443

Table 1 Primary studies included.

Author	Year	Study identifier	Sample size	Study population	Study period	Outcomes assessed
Janatuinen et al⁶	1995	J1	92	40 adults with newly diagnosed CD, 52 adults with CD in remission	6–12 months	Marsh Score, GSRS, physical examinations, IEL count, laboratory values
Janatuinen et al⁷	2000	J2	92	40 adults with new diagnosed CD, 52 adults with CD in remission	6–12 months	Serology, IEL count
Janatuinen et al⁸	2002	J3	63	63 adults with CD	5 years	Marsh Score, IEL count, serology
Reunala et al¹⁰	1998	R	23	23 adults with DH on a standard GFD	6 months	Villous height:depth ratio, IEL count, rash presence, skin biopsy, serum samples
Peräaho et al¹³	2004	P	39	39 adults with CD on a standard GFD	12 months	GSRS, quality of life, IEL count, serology
Högberg et al¹⁴	2004	H	116	116 children with newly diagnosed CD	12 months	Villous height:depth ratio, IEL count, serology

CD, coeliac disease; DH, dermatitis herpetiformis; GFD, gluten‐free diet; GSRS, Gastrointestinal Symptom Rating Scale; IEL, intraepithelial lymphocyte.